Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-25
DOI: 10.2147/ijn.s642461 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Sara Mehri und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mehri, S., Shourian, M., Kheirkhah, A. H., & Reihani, N. (2026). Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy. International Journal of Nanomedicine, Volume 21, 1-25. https://doi.org/10.2147/ijn.s642461
Vancouver
Mehri S, Shourian M, Kheirkhah AH, Reihani N. Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-25. doi:10.2147/ijn.s642461
BibTeX
@article{Mehri2026,
author = {Mehri, Sara and Shourian, Mostafa and Kheirkhah, Amir Hossein and Reihani, Nasim},
title = {Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--25},
doi = {10.2147/ijn.s642461}
}
EUVIMED